IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.002
AS - Asia 5.009
EU - Europa 2.902
SA - Sud America 632
AF - Africa 94
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 30.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.843
SG - Singapore 2.711
CN - Cina 809
RU - Federazione Russa 524
IT - Italia 522
BR - Brasile 512
HK - Hong Kong 448
VN - Vietnam 378
DE - Germania 344
FI - Finlandia 266
GB - Regno Unito 241
IE - Irlanda 241
UA - Ucraina 209
FR - Francia 155
IN - India 139
JP - Giappone 139
KR - Corea 104
CA - Canada 90
NL - Olanda 83
SE - Svezia 80
MX - Messico 50
AR - Argentina 48
ES - Italia 48
ID - Indonesia 44
BD - Bangladesh 43
TR - Turchia 42
AT - Austria 40
PL - Polonia 35
BE - Belgio 26
ZA - Sudafrica 24
IQ - Iraq 21
EG - Egitto 20
EC - Ecuador 19
CZ - Repubblica Ceca 18
CO - Colombia 15
AU - Australia 14
CH - Svizzera 13
NG - Nigeria 12
PH - Filippine 12
MY - Malesia 11
SA - Arabia Saudita 11
CL - Cile 10
KE - Kenya 10
GR - Grecia 9
HR - Croazia 9
TH - Thailandia 9
UZ - Uzbekistan 9
IR - Iran 8
JO - Giordania 8
TN - Tunisia 8
VE - Venezuela 8
AZ - Azerbaigian 7
EU - Europa 7
AE - Emirati Arabi Uniti 6
LT - Lituania 6
MA - Marocco 6
MD - Moldavia 6
PK - Pakistan 6
PY - Paraguay 6
IL - Israele 5
PE - Perù 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
HU - Ungheria 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NP - Nepal 4
PT - Portogallo 4
RO - Romania 4
TM - Turkmenistan 4
DK - Danimarca 3
JM - Giamaica 3
KH - Cambogia 3
KZ - Kazakistan 3
SN - Senegal 3
TW - Taiwan 3
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
KW - Kuwait 2
LB - Libano 2
ML - Mali 2
MT - Malta 2
NO - Norvegia 2
PA - Panama 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
Totale 30.643
Salva come PNG Salva come JPEG
Città #
Wilmington 5.240
Houston 4.828
Woodbridge 4.195
Singapore 1.244
Fairfield 772
Ashburn 609
San Jose 507
Ann Arbor 469
Chandler 444
Hong Kong 435
New York 414
Beijing 340
Seattle 308
Cambridge 280
Dublin 232
Council Bluffs 229
Santa Clara 225
Helsinki 200
Medford 180
Jacksonville 168
Los Angeles 162
The Dalles 151
Tokyo 128
Rome 116
Ho Chi Minh City 115
Zhengzhou 101
Hanoi 93
Buffalo 90
Elk Grove Village 86
Lawrence 84
Moscow 84
Lauterbourg 78
Dearborn 72
São Paulo 68
Orem 56
Chicago 55
San Diego 50
Creede 45
London 43
Munich 41
Chennai 40
Milan 38
Dallas 37
North Bergen 36
Menlo Park 34
Montreal 31
Jakarta 30
Atlanta 28
Frankfurt am Main 28
Mülheim 28
Denver 27
Shanghai 27
Warsaw 26
Boardman 25
Nuremberg 25
Toronto 25
Brooklyn 23
Nanjing 23
Amsterdam 22
Johannesburg 22
Manchester 22
Palo Alto 22
Poplar 22
Redondo Beach 22
Stockholm 22
Lappeenranta 21
Vienna 21
Brussels 19
Mexico City 18
Mountain View 16
Norwalk 16
Phoenix 16
Redwood City 16
Salt Lake City 16
San Francisco 16
Seoul 16
Turin 16
Jersey City 15
Rio de Janeiro 15
Dong Ket 14
Ankara 13
Hefei 13
Madrid 13
Miami 13
Verona 13
Brasília 12
Engelhard 12
Guangzhou 11
Istanbul 11
Da Nang 10
Mumbai 10
Curitiba 9
Genoa 9
Haiphong 9
Hounslow 9
Islington 9
Nairobi 9
Olomouc 9
Pune 9
Querétaro 9
Totale 24.185
Salva come PNG Salva come JPEG
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 611
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 522
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 519
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 505
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 500
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 496
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 491
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 487
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 479
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 470
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 468
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 463
Marginal donors in liver transplantation. 460
Use of mycophenolate mofetil in liver transplantation: a literature review. 459
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 458
596 454
Management of spermatic cord liposarcoma in renal transplant recipients: case report 446
Liver abscess caused by foreign body ingestion 446
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 446
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 443
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 442
Immunosuppression-Free Liver Transplantation 435
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 433
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 426
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 425
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 424
Liver transplantation for the treatment of nodular regenerative hyperplasia 420
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 419
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 418
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 416
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 411
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 409
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 400
Prospect for kidney bioengineering: Shortcomings of the status quo 390
Myopericytoma of the Liver Hilus: A Case Report 377
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 374
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 367
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 362
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 360
An unusual duodenal polyp causing anemia in a liver-transplanted patient 344
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 339
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 328
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 327
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 318
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 308
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 303
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 299
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 299
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 287
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 272
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 258
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 252
Rare malignant glomus tumor of the stomach with liver metastases 236
Platelets and hepatocellular cancer: Bridging the bench to the clinics 221
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 219
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 217
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 212
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 211
Liver transplantation for hepatocellular carcinoma: Where do we stand? 208
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 205
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 199
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 199
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 196
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 194
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 189
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 184
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 180
Abdominal organ bioengineering: current status and future perspectives 178
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 171
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 162
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 151
Immunosuppression in adult liver transplant recipients: a 2024 update from the Italian Liver Transplant Working Group 133
Moving forward in the treatment of cholangiocarcinoma 127
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 118
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 118
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 115
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 112
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 102
Chronic rejection after liver transplantation: Opening the Pandora's box 102
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 100
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 100
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 98
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 95
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 93
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 93
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy 90
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 90
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 90
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 85
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 85
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy 85
Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients 84
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 84
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 84
Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis 83
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 83
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 82
Cell transplantation-based regenerative medicine in liver diseases 82
Towards tolerance in liver transplantation 82
Totale 28.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021153 0 0 0 0 0 0 0 0 0 0 91 62
2021/2022909 52 87 14 32 24 92 61 28 120 116 54 229
2022/20231.371 138 120 15 144 108 251 106 250 100 12 92 35
2023/2024676 76 38 81 17 93 163 32 12 16 37 8 103
2024/20254.099 94 753 446 230 40 283 306 116 327 347 666 491
2025/20266.573 595 285 623 671 685 446 895 900 805 570 98 0
Totale 31.328